[1]
I. Ghemlas, “Post-Induction Minimal Residual Disease in Pediatric Pre-B-Cell Acute Lymphoblastic Leukemia: A Step Towards Precision Medicine?”, J Hematol, vol. 14, no. 2, pp. 56–65, Apr. 2025, doi: 10.14740/jh1375.